Stephens Consulting’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-45
Closed -$359 1922
2025
Q1
$359 Buy
+45
New +$455 ﹤0.01% 1278
2022
Q1
Sell
-90
Closed -$8.26K 680
2021
Q4
$8.26K Buy
+90
New +$10.8K 0.01% 421

Other funds holding TDOC

Stephens Consulting's TDOC Position: Q2 2025 in Review

Stephens Consulting sold out of Teladoc Health (TDOC) in Q2 2025, closing a stake of 45 shares — an estimated $359 sold.

Stephens Consulting first reported a position in TDOC in Q4 2021 and held it in 2 quarters. The position peaked at $8.26K in Q4 2021. 358 funds tracked by Wall St. Rank hold TDOC as of Q2 2025.

  • Stephens Consulting reported no remaining Teladoc Health position as of Q2 2025 after selling out during the quarter.
  • Stephens Consulting sold 45 Teladoc Health shares in Q2 2025, an estimated $359.
  • Stephens Consulting first reported a position in Teladoc Health in Q4 2021 and held it in 2 quarters.
  • Stephens Consulting's Teladoc Health position peaked at $8.26K in Q4 2021.
  • 358 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2025.

Based on Stephens Consulting's 13F filing for Q2 2025, filed 25 Jul 2025.